Swati Abbott - Magellan Health Director
Director
Ms. Swati Abbott is Independent Director of the Company. She currently serves as the president and chief executive officer of Health Intelligence Company LLC, doing business as Blue Health Intelligence, a healthcare data and analytics company, a post that she has held since 2011. Prior to joining Blue Health Intelligence, Ms. Abbott served as the president of MEDai, Inc., an industry leader in predictive analytics which was acquired by Reed Elsevier in 2008. She also served as managing director for the Medical Management Strategic Business Unit at ViPS. Ms. Abbott was nominated for the first time for election as a director in 2018 due to her knowledge and experience in healthcare data analytics and managed care generally. since 2018.
Age | 53 |
Tenure | 6 years |
Phone | 800 642-1716 |
Web | www.magellanhealth.com |
Magellan Health Management Efficiency
The company has return on total asset (ROA) of 0.54 % which means that it generated a profit of $0.54 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.16) %, meaning that it created substantial loss on money invested by shareholders. Magellan Health's management efficiency ratios could be used to measure how well Magellan Health manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 562.64 M in liabilities with Debt to Equity (D/E) ratio of 0.28, which may suggest the company is not taking enough advantage from borrowing. Magellan Health has a current ratio of 2.86, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Magellan Health until it has trouble settling it off, either with new capital or with free cash flow. So, Magellan Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Magellan Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Magellan to invest in growth at high rates of return. When we think about Magellan Health's use of debt, we should always consider it together with cash and equity.
Similar Executives
Showing other executives | DIRECTOR Age | ||
Erin Nelson | Skyline | 50 | |
John Firth | Skyline | 60 | |
Lance Fritz | Parker Hannifin | 57 | |
William Fuerst | Paul Mueller Co | N/A | |
Carolyn Corvi | United Airlines Holdings | 66 | |
Robert Milton | United Airlines Holdings | 55 | |
Robert Kohlhepp | Parker Hannifin | 72 | |
William Lacey | Parker Hannifin | 55 | |
Todd Insler | United Airlines Holdings | 49 | |
Patrick Hanley | Old Dominion Freight | 73 | |
Jane Garvey | United Airlines Holdings | 74 | |
James Hlavacek | Paul Mueller Co | N/A | |
Barbara Allen | DR Horton | 74 | |
James Kennedy | United Airlines Holdings | 64 | |
David Smith | Skyline | N/A | |
Laurence Simmons | United Airlines Holdings | 69 | |
Jillian Evanko | Parker Hannifin | 42 | |
Jerry Hammes | Skyline | 84 | |
John Kasarda | Old Dominion Freight | 72 | |
Walter Isaacson | United Airlines Holdings | 65 | |
James Wainscott | Parker Hannifin | 63 |
Management Performance
Return On Equity | -0.16 | |||
Return On Asset | 0.54 |
Magellan Health Leadership Team
Elected by the shareholders, the Magellan Health's board of directors comprises two types of representatives: Magellan Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Magellan. The board's role is to monitor Magellan Health's management team and ensure that shareholders' interests are well served. Magellan Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Magellan Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Eran Broshy, Independent Director | ||
Swati Abbott, Director | ||
Mostafa Kamal, Senior Vice President and General Manager | ||
Scott MacKenzie, Independent Director | ||
Barry Smith, Chairman and CEO | ||
Mary Sammons, Independent Director | ||
Joe Bogdan, Senior Vice President Corporate Finance | ||
Steven Shulman, Independent Director | ||
Matthew Simas, Director | ||
Perry Fine, Independent Director | ||
Daniel Gregoire, General Counsel and Secretary | ||
Kay James, Director | ||
Srinivas Koushik, CTO | ||
Leslie Norwalk, Independent Director | ||
John Agwunobi, Independent Director | ||
John Littel, Senior Vice President - Government Affairs and Communications | ||
Michael Diament, Independent Director | ||
William McBride, Independent Director | ||
Guy Sansone, Independent Director | ||
Peter Feld, Independent Director | ||
Renie Shapiro, Senior Vice President Corporate Finance | ||
Michael Ressner, Independent Director | ||
Sanjeev Srivastava, CEO of Magellan Healthcare | ||
Caskie LewisClapper, Chief Human Resource Officer |
Magellan Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Magellan Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.16 | |||
Return On Asset | 0.54 | |||
Profit Margin | 6.26 % | |||
Operating Margin | 0.60 % | |||
Current Valuation | 2.09 B | |||
Shares Outstanding | 26.33 M | |||
Shares Owned By Insiders | 1.64 % | |||
Shares Owned By Institutions | 98.36 % | |||
Number Of Shares Shorted | 1.16 M | |||
Price To Earning | 8.49 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Magellan Stock
If you are still planning to invest in Magellan Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Magellan Health's history and understand the potential risks before investing.
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |